Lung Academy 2024-2025

Next Wave Forum for Young Investigators in Thoracic Oncology
May 10-11, 2024; Atlanta, Georgia

Jointly provided by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC.

This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc. 

Target Audience

This activity is intended for physicians who care for patients with lung cancer.

Learning Objectives

  • Evaluate current and emerging therapeutic approaches, including appropriate treatment selection, for patients with lung cancer, including deciding among traditional chemotherapy, radiotherapy, targeted agents, or immunotherapy
  • Acquire skills and insights from expert faculty in thoracic oncology that will help foster the further personal and professional growth of fellows and junior faculty involved in the clinical care of patients with lung cancer
  • Identify strategies to increase clinician and patient participation in clinical trials in order to introduce novel agents into practice that improve the outcomes of lung cancer patients with unmet needs

Disclosure of Conflicts of Interest

PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Julie R. Brahmer, MD, MSc – Co-Chair
Consultant/Advisor/Speaker: GSK, AstraZeneca, Johnson & Johnson, Merck, Sanofi, Regeneron, Amgen; Researcher: AstraZeneca

Suresh Ramalingam, MD, FACP, FASCO – Co-Chair
Has no relevant financial relationships

Tina Cascone, MD, PhD
Consultant/Advisor/Speaker: AstraZeneca, Bio Ascend LLC, Bristol Myers Squibb, Roche, Targeted Oncology, Arrowhead Pharmaceuticals, AstraZeneca, Bristol Myers Squibb, Genentech, Merck, ONKo-innate, Pfizer, Regeneron; Researcher: AstraZeneca, Bristol Myers Squibb and EMD Serono

Shirish Gadgeel, MD
Advisory Board: Amgen, AZ, Bayer, BMS, Daichii, Esai, Genentech/Roche, Gilead, Lilly, Merck, Mirati, Pfizer, Regeneron, Takeda; Other: AZ (DSMB), Merck (travel support), Mirati (travel support)

Ramaswamy Govindan, MD
Has no relevant financial relationships

Nasser Hanna, MD
Researcher: Genentech, Natera, Merck, BMS

Mark Kris, MD
Consultant/Advisor/Speaker: AstraZeneca, BMS, Daiichi Sankyo, Merus, Mirati Therapeutics, Sanofi; Other – Roche Genentech

Natasha Leighl, MD, MMSc, PhD, FRCP, FASCO
Grant Funding: Astra Zeneca, Bayer, Eli Lilly, EMD Serono, Guardant Health, Inivata, Janssen, Merck, Novartis, Pfizer, Roche, Takeda; Speaker: Beigene, BMS, Janssen, Merck, Novartis, Takeda; Other (travel support): AZ, Janssen, Sanofi, MSD, Guardant Health, Roche

Rachel Sanborn, MD
Consultant/Advisor/Speaker: EMD Serono, Daiichi Sankyo, Janssen Oncology, Sanofi Aventis, BeiGene, AstraZeneca, Gilead, Inhibrx, Johnson & Johnson, Illumina

Lecia Sequist, MD, MPH
Researcher: AstraZeneca, Novartis, Delfi Diagnositics

Gary L. Teal, MBA
Has no relevant financial relationships

Investigators

Fatemeh Ardeshir-Larijani, MD, MSc
Has no relevant financial relationships

Christine E. Auberle, MD
Has no relevant financial relationships

Ayse Ece Cali Daylan, MD, PhD
Has no relevant financial relationships

Giordano Fabricio Cittolin-Santos, MD, PhD
Has no relevant financial relationships

Alissa J. Cooper, MD
Consultant/Advisor/Speaker: MJH Life Sciences, Gilead

Colum Dennehy, MBBCh, MSc
Has no relevant financial relationships

Nadia Ghazali, MBBS
Has no relevant financial relationships

Radhika Gutta, DO
Has no relevant financial relationships

Sam Khan, MBChB, MRes, PhD, MRCP
Has no relevant financial relationships

June-Koo (Jake) Lee, MD, PhD
Has no relevant financial relationships

Koosha Paydary, MD, MPH, MSc
Has no relevant financial relationships

Abdul Rafae, MBBS
Has no relevant financial relationships

Amanda Reyes, MD, MS
Has no relevant financial relationships

Ivy L. Riano, MD
Has no relevant financial relationships

Susan Scott, MD
Consultant/Advisor/Speaker: Janssen, AstraZeneca, Genentech, Diiachi Sankyo, Regeneron, Tempus; Researcher: Janssen, Mirati

Chetan Vakkalagadda, MD
Consultant/Advisor/Speaker: Takeda

Victoria E. Wang, MD, PhD
Researcher: Inhibrx; Individual publicly traded stocks and stock options: Nuvalent, BMS, Gilead

Yating Wang, MD
Has no relevant financial relationships

Urs Michael Weber, MD
Has no relevant financial relationships

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact bunyasaranand@bioascend.com prior to the live event.

Fee Information

There is no fee for this educational activity.

Joint Accreditation Statement

Resim1

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How To Claim Credit

To receive CE credit, learners must follow these steps:

  1. Visit https://paceducation.com/NextWaveLung2024
  2. Complete the activity evaluation
  3. Upon completion of all evaluation questions, your credit will be made available for download immediately